Premenopausal Patients with Node-Positive Resectable Breast Cancer: Preliminary Results of a Randomised Trial Comparing 3 Adjuvant Regimens: FEC 50 × 6 Cycles vs FEC 50 × 3 Cycles vs FEC 75 × 3 Cycles